Nimodipine Suppliers & Bulk Manufacturers

Available Forms: Tablet/ Injection

Available Strengths: 30 mg

Reference Brands: Nimotop (USA)

Category: Neurology

Product Description:

Nimodipine is a second-generation 1,4-dihydropyridine calcium channel blocker that was initially approved for the management of hypertension. In current clinical practice, it is primarily used to prevent and manage cerebral vasospasm following subarachnoid hemorrhage, a condition that can lead to severe neurological complications. Nimodipine acts by selectively blocking calcium channels in cerebral blood vessels, resulting in vasodilation and improved cerebral blood flow, which helps reduce the risk of ischemic brain injury.

Nimodipine is available in multiple dosage forms, including oral capsules, oral solutions, and intravenous infusions, allowing flexibility in administration based on patient condition and clinical setting. Its ability to cross the blood–brain barrier makes it particularly effective in targeting cerebral vasculature. In addition to its approved indication, nimodipine has been explored for off-label uses in various neurological conditions.

Appropriate administration of nimodipine requires careful consideration of dosing schedules, contraindications, and potential adverse effects such as hypotension, headache, and gastrointestinal disturbances. Continuous monitoring by healthcare professionals is essential to optimize therapeutic outcomes and minimize risks. Proper understanding of nimodipine’s pharmacology supports effective treatment and improved patient outcomes in subarachnoid hemorrhage management.